[1]
|
Miao, Z., Zhang, S., Ou, X., et al. (2020) Estimating the Global Prevalence, Disease Progression, and Clinical Outcome of Hepatitis Delta Virus Infection. The Journal of Infectious Diseases, 221, 1677-1687.
https://doi.org/10.1093/infdis/jiz633
|
[2]
|
Dias, J., Hengst, J., Parrot, T., et al. (2019) Chronic Hepatitis Delta Virus Infection Leads to Functional Impairment and Severe Loss of MAIT Cells. Journal of Hepatology, 71, 301-312. https://doi.org/10.1016/j.jhep.2019.04.009
|
[3]
|
Tham, C., Kah, J., Tan, A.T., et al. (2020) Hepatitis Delta Virus Acts as an Immunogenic Adjuvant in Hepatitis B Virus -Infected Hepatocytes. Cell Reports Medicine, 1, Article ID: 100060. https://doi.org/10.1016/j.xcrm.2020.100060
|
[4]
|
Vieira Barbosa, J., Sahli, R., Aubert, V., et al. (2021) Demographics and Outcomes of Hepatitis B and D:A 10-Year Retrospective Analysis in a Swiss Tertiary Referral Center. PLOS ONE, 16, e0250347.
https://doi.org/10.1371/journal.pone.0250347
|
[5]
|
Sagnlli, C., Sagnelli, E., Russo, A., et al. (2021) HBV/HDV Coinfection: Epidemiological and Clinical Changes, Recent Knowledge and Future Challenges. Life (Basel), 11, Article No. 169. https://doi.org/10.3390/life11020169
|
[6]
|
Rizzetto, M., Canese, M.G., Aricò, S., Crivelli, O., Trepo, C., Bonino, F., et al. (1977) Immunofluorescence Detection of New Antigen-Antibody System (Delta/Antidelta) Associated to Hepatitis B Virus in Liver and in Serum of HBsAg Carriers. Gut, 18, 997-1003. https://doi.org/10.1136/gut.18.12.997
|
[7]
|
Canese, M.G., Rizzetto, M., Arico, S., Crivelli, O., Zanetti, A.R., Mac-chiorlatti, E., et al. (1979) An Ultrastructural and Immunohistochemical Study on the Delta Antigen Associated with the Hepatitis B Virus. The Journal of Pathology, 128, 169-175. https://doi.org/10.1002/path.1711280402
|
[8]
|
Rizzetto, M., Canese, M.G., Gerin, J.L., London, W.T., Sly, D.L. and Purcell, R.H. (1980) Transmission of the Hepatitis B Vi-rus-Associated Delta Antigen to Chimpanzees. The Journal of Infectious Diseases, 141, 590-602.
https://doi.org/10.1093/infdis/141.5.590
|
[9]
|
Fu, T.B. and Taylor, J. (1993) The RNAs of Hepatitis Delta Virus Are Copied by RNA Polymerase II in Nuclear Homogenates. Journal of Virology, 67, 6965-6972. https://doi.org/10.1128/jvi.67.12.6965-6972.1993
|
[10]
|
Rizzetto, M. (2016) The Adventure of Delta. Liver Interna-tional, 36, 135-140. https://doi.org/10.1111/liv.13018
|
[11]
|
Wu, H.N., Lin, Y.J., Lin, F.P., Makino, S., Chang, M.F. and Lai, M.M. (1989) Human Hepatitis Delta Virus RNA Subfragments Contain an Autocleavage Activity. Proceedings of the National Academy of Sciences of the United States of America, 86, 1831-1835. https://doi.org/10.1073/pnas.86.6.1831
|
[12]
|
Salehi-Ashtiani, K., Lupták, A., Litovchick, A. and Szostak, J.W. (2006) A Genomewide Search for Ribozymes Reveals an HDV-Like Sequence in the Human CPEB3 Gene. Science, 313, 1788-1792.
https://doi.org/10.1126/science.1129308
|
[13]
|
Branch, A.D., Benenfeld, B.J., Baroudy, B.M., Wells, F.V., Gerin, J.L. and Robertson, H.D. (1989) An Ultraviolet-Sensitive RNA Structural Element in a Viroid-Like Domain of the Hepa-titis Delta Virus. Science, 243, 649-652.
https://doi.org/10.1126/science.2492676
|
[14]
|
Gilman, C., Heller, T. and Koh, C. (2019) Chronic Hepatitis Delta: A State-of-the-Art Review and New Therapies. World Journal of Gastroenterology, 25, 4580-4597. https://doi.org/10.3748/wjg.v25.i32.4580
|
[15]
|
Lempp, F.A., Ni, Y. and Urban, S. (2016) Hepatitis Delta Virus: In-sights into a Peculiar Pathogen and Novel Treatment Options. Nature Reviews Gastroenterology & Hepatology, 13, 580-589.
https://doi.org/10.1038/nrgastro.2016.126
|
[16]
|
Su, C.W., Huang, Y.H., Huo, T.I., et al. (2006) Genotypes and Vi-remia of Hepatitis B and D Viruses Are Associated with Outcomes of Chronic Hepatitis D Patients. Gastroenterology, 130, 1625-1635.
https://doi.org/10.1053/j.gastro.2006.01.035
|
[17]
|
王彦. 我国丁型肝炎病毒感染情况调查和病毒分子特性研究[D]: [博士学位论文]. 北京: 中国疾病预防控制中心, 2018.
|
[18]
|
Yan, H., Zhong, G., Xu, G., et al. (2012) Sodium Taurocholate Cotransporting Polypeptide Is a Functional Receptor for Human Hepatitis B and D Virus. Elife, 1, e00049.
|
[19]
|
Hercun, J., Koh, C. and Heller, T. (2020) Hepatitis Delta: Prevalence, Natural History, and Treatment Op-tions. Gastroenterology Clinics of North America, 49, 239-252. https://doi.org/10.1016/j.gtc.2020.01.004
|
[20]
|
Fattovich, G., Giustina, G., Christensen, E., et al. (2000) Influence of Hepatitis Delta Virus Infection on Morbidity and Mortality in Compensated Cirrhosis Type B. Gut, 46, 420-426. https://doi.org/10.1136/gut.46.3.420
|
[21]
|
Shen, L., Gu, Y., Sun, L., et al. (2012) Development of a Hepatitis Delta Virus Antibody Assay for Study of the Prevalence of HDV among Individuals Infected with Hepatitis B Virus in China. Journal of Medical Virology, 84, 445-449. https://doi.org/10.1002/jmv.23212
|
[22]
|
Mumtaz, K., Ahmed, U.S., Memon, S., et al. (2011) Virological and Clinical Characteristics of Hepatitis Delta Virus in South Asia. Virology Journal, 8, Article No. 312. https://doi.org/10.1186/1743-422X-8-312
|
[23]
|
Sureau, C. and Negro, F. (2016) The Hepatitis Delta Virus: Replication and Pathogenesis. Journal of Hepatology, 64, S102-S116. https://doi.org/10.1016/j.jhep.2016.02.013
|
[24]
|
Ciancio, A. and Rizzetto, M. (2014) Chronic Hepatitis D at a Standstill: Where Do We Go from Here? Nature Reviews Gastroenterology & Hepatology, 11, 68-71. https://doi.org/10.1038/nrgastro.2013.164
|
[25]
|
Chen, H.-Y., Shen, D.-T., Ji, D.-Z., Han, P.-C., Zhang, W.-M., Ma, J.-F., Chen, W.-S., Goyal, H., Pan, S. and Xu, H.-G. (2019) Prevalence and Burden of Hepatitis D Virus Infection in the Global Population: A Systematic Review and Meta-Analysis. Gut, 68, 512-521. https://doi.org/10.1136/gutjnl-2018-316601
|
[26]
|
Wedemeyer, H. and Manns, M.P. (2010) Epidemiology, Patho-genesis and Management of Hepatitis D: Update and Challenges Ahead. Nature Reviews Gastroenterology & Hepatology, 7, 31-40.
https://doi.org/10.1038/nrgastro.2009.205
|
[27]
|
Stroffolini, T., Almasio, P.L., Sagnelli, E., Mele, A., Gaeta, G.B. and Messina, V. (2009) Evolving Clinical Landscape of Chronic Hepatitis B: A Multicenter Italian Study. Journal of Medical Virology, 81, 1999-2006.
https://doi.org/10.1002/jmv.21643
|
[28]
|
Cross, T.J., Rizzi, P., Horner, M., Jolly, A., Hussain, M.J., Smith, H.M., Vergani, D. and Harrison, P.M. (2007) The Increasing Prevalence of Hepatitis Delta Virus (HDV) Infection in South London. Journal of Medical Virology, 80, 277-282. https://doi.org/10.1002/jmv.21078
|
[29]
|
Romeo, R., Del Ninno, E., Rumi, M., Russo, A., SanGiovanni, A., De Franchis, R., Ronchi, G. and Colombo, M. (2009) A 28-Year Study of the Course of Hepatitis D Infection: A Risk Factor for Cirrhosis and Hepatocellular Carcinoma. Gastroenterology, 136, 1629-1638. https://doi.org/10.1053/j.gastro.2009.01.052
|
[30]
|
Niro, G.A., Smedile, A., Ippolito, A.M., Ciancio, A., Fontana, R., Olivero, A., Valvano, M.R., Abate, M.L., Gioffreda, D., Caviglia, G.P., et al. (2010) Outcome of Chronic Delta Hepatitis in Italy: A Long-Term Cohort Study. Journal of Hepatology, 53, 834-840. https://doi.org/10.1016/j.jhep.2010.06.008
|
[31]
|
Buti, M., Homs, M., Rodriguez-Frias, F., Funalleras, G., Jardí, R., Sauleda, S., Tabernero, D., Schaper, M. and Esteban, R. (2011) Clinical Outcome of Acute and Chronic Hepatitis Delta over Time: A Long-Term Follow-Up Study. Journal of Viral Hepatitis, 18, 434-442. https://doi.org/10.1111/j.1365-2893.2010.01324.x
|
[32]
|
Farci, P. and Niro, G.A. (2012) Clinical Features of Hepa-titis D. Seminars in Liver Disease, 32, 228-236.
https://doi.org/10.1055/s-0032-1323628
|
[33]
|
Sagnelli, E., Felaco, F.M., Filippini, P., Pasquale, G., Peinetti, P., Buonagurio, E., Aprea, L., Pulella, C., Piccinino, F. and Giusti, G. (2008) Influence of HDV Infection on Clinical, Bio-chemical and Histological Presentation of HBsAg Positive Chronic Hepatitis. Liver International, 9, 229-234. https://doi.org/10.1111/j.1600-0676.1989.tb00404.x
|
[34]
|
Perez-Vargas, J., Amirache, F., Boson, B., Mialon, C., Freitas, N., Sureau, C., Fusil, F. and Cosset, F.L. (2019) Enveloped Viruses Distinct from HBV Induce Dissemination of Hepatitis D Virus in Vivo. Nature Communications, 10, Article No. 2098. https://doi.org/10.1038/s41467-019-10117-z
|
[35]
|
Fattovich, G., Boscaro, S., Noventa, F., et al. (1987) Influence of Hepatitis Delta Virus Infection on Progression to Cirrhosis in Chronic Hepatitis Type B. Journal of Infectious Diseases, 155, 931-935.
https://doi.org/10.1093/infdis/155.5.931
|
[36]
|
Toukan, A.U., Abu-El-Rub, O.A., Abu-Laban, S.A., et al. (1987) The Epidemiology and Clinical Outcome of Hepatitis D Virus (Delta) Infection in Jordan. Hepatology, 7, 1340-1345. https://doi.org/10.1002/hep.1840070627
|
[37]
|
Brichler, S., Le Gal, F., Butt, A., et al. (2013) Commercial Real-Time Reverse Transcriptase PCR Assays Can Underestimate or Fail to Quantify Hepatitis Delta Virus Viremia. Clinical Gas-troenterology and Hepatology, 11, 734-740.
https://doi.org/10.1016/j.cgh.2013.01.025
|
[38]
|
Lu, X.X., Yi, Y., Su, Q.D., et al. (2016) Expression and Purifica-tion of Recombinant Hepatitis Delta Virus (HDV) Antigen for Use in a Diagnostic ELISA for HDV Infection Using the High-Density Fermentation Strategy in Escherichia coli. Biomedical and Environmental Sciences, 29, 417-423.
|
[39]
|
Gu, W.J., Huang, W.J., Zhou, C., et al. (2011) Evaluate the HDV Diagnostic Kits (EIA) with HBV Surface Antigen Positive Sera. Chinese Pharmaceutical Affairs, 25, 866-868+879.
|
[40]
|
Taylor, J.M. (2020) Infection by Hepatitis Delta Virus. Viruses, 12, Article No. 648.
https://doi.org/10.3390/v12060648
|
[41]
|
Kohli, A., Zhang, X., Yang, J., Russell, R.S., Donnelly, R.P., Sheikh, F., et al. (2012) Distinct and Overlapping Genomic Profiles and Antiviral Effects of Interferon-Lambda and -Alpha on HCV-Infected and Noninfected Hepatoma Cells. Journal of Viral Hepatitis, 19, 843-853. https://doi.org/10.1111/j.1365-2893.2012.01610.x
|
[42]
|
de Groen, R.A., Boltjes, A., Hou, J., Liu, B.S., McPhee, F., Friborg, J., et al. (2014) IFN-Lambda-Mediated IL-12 Production in Macrophages Induces IFN-Gamma Production in Human NK Cells. European Journal of Immunology, 45, 250-259. https://doi.org/10.1002/eji.201444903
|
[43]
|
Duong, F.H., Trincucci, G., Boldanova, T., Calabrese, D., Campana, B., Krol, I., et al. (2014) IFN-Lambda Receptor 1 Expression Is Induced in Chronic Hepatitis C and Correlates with the IFN-lambda3 Genotype and with Nonresponsiveness to IFN-Alpha Therapies. Journal of Experimental Medicine, 211, 857-868.
https://doi.org/10.1084/jem.20131557
|
[44]
|
Levy, D.E., Marie, I.J. and Durbin, J.E. (2011) Induction and Function of Type I and III Interferon in Response to Viral Infection. Current Opinion in Virology, 1, 476-486. https://doi.org/10.1016/j.coviro.2011.11.001
|
[45]
|
Francois-Newton, V., Magno de Freitas Almeida, G., Payelle-Brogard, B., Monneron, D., PichardGarcia, L., Piehler, J., et al. (2011) USP18-Based Negative Feedback Con-trol Is Induced by Type I and Type III Interferons and Specifically Inactivates Interferon Alpha Response. PLOS ONE, 6, e22200. https://doi.org/10.1371/journal.pone.0022200
|
[46]
|
Muir, A.J., Arora, S., Everson, G., Flisiak, R., George, J., Ghalib, R., et al. (2014) A Randomized Phase 2b Study of Peginterferon Lambda-1a for the Treatment of Chronic HCV Infection. Journal of Hepatology, 61, 1238-1246.
https://doi.org/10.1016/j.jhep.2014.07.022
|
[47]
|
Buster, E.H., Hansen, B.E., Lau, G.K., Piratvisuth, T., Zeuzem, S., Steyerberg, E.W., et al. (2009) Factors That Predict Response of Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B to Peginterferon-Alfa. Gastroenterology, 137, 2002-2009. https://doi.org/10.1053/j.gastro.2009.08.061
|
[48]
|
Cooksley, W.G., Piratvisuth, T., Lee, S.D., Mahachai, V., Chao, Y.C., Tanwandee, T., et al. (2003) Peginterferon Alpha-2a (40 kDa): An Advance in the Treatment of Hepatitis B e An-tigen-Positive Chronic Hepatitis B. Journal of Viral Hepatitis, 10, 298-305. https://doi.org/10.1046/j.1365-2893.2003.00450.x
|
[49]
|
Wong, D.K., Cheung, A.M., O’Rourke, K., Naylor, C.D., Detsky, A.S. and Heathcote, J. (1993) Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Anti-gen-Positive Chronic Hepatitis B. A Meta-Analysis. Annals of Internal Medicine, 119, 312-323. https://doi.org/10.7326/0003-4819-119-4-199308150-00011
|